好,给你写一篇完整的 Indie Hackers post,直接可以发布。
标题:
I built an AI tool that catches the methodology flaws hidden in clinical trial abstracts
正文:
A few months ago, I kept noticing the same problem when using general AI to read medical papers: ask ChatGPT to summarize a clinical trial, and it will faithfully repeat the headline number — "25% relative risk reduction!" — without ever questioning whether that number means anything clinically.
Here's the thing: a trial reporting a 25% relative risk reduction can translate to an absolute benefit of 1% or less. The difference between "this changes clinical practice" and "this barely matters" often lives in details that general AI summarizers skip entirely:
Surrogate endpoints that don't actually predict the outcome that matters
Composite endpoints hiding components moving in opposite directions (fewer heart attacks, but more deaths)
Early termination that inflates the apparent effect size
Whether the evidence quality (GRADE) actually supports the stated conclusion
I ran into a real example early on: the ACCORD trial (NEJM, 2008). Intensive glucose control looked like an obviously good idea — lower HbA1c should reduce cardiovascular risk. The trial was stopped early. Not because it worked too well — because the intensive group had a higher mortality rate. A "neutral" composite endpoint was quietly hiding a mortality signal moving the wrong direction.
That's the kind of thing a clinical epidemiologist catches by habit. I wanted a tool that does the same appraisal automatically — recomputing absolute risk (ARR/NNT), flagging bias and design flaws, rating evidence quality with GRADE, and giving a clear bottom-line judgment on whether the evidence actually supports the claim.
What it does:
Paste an abstract or full text (or upload a PDF) → get a structured evidence appraisal
Two modes: Expert (for clinicians/reviewers — A/B/C/D confidence rating, inline citations) and Teaching (for students — walks through concepts, includes a "pre-defense" mode that flags the methodology questions your committee is likely to ask)
Covers RCTs, meta-analyses, observational studies, and more
Available in English and Chinese
You can see real examples (including the ACCORD case above) at trialreviewer.com/sample — no signup needed to browse those.
Would love feedback from anyone who reads clinical literature regularly — what would make this actually useful in your workflow, and what am I missing?